Bionorica has sold C³ to Canopy Growth
Bionorica has sold its cannabis business, C³, to Canopy Growth Corporation, a world-leading diversified cannabis and hemp company based in Smiths Falls, Canada. The selling price amounts to Euro 225.9 million. The strategic goal is to quickly and consistently develop and expand the international markets to meet the needs of a steadily growing number of patients. Bionorica will support Canopy Growth in this regard in future. Both parties see great opportunities in the further clinical research of the cannabis plant and its constituents. To this end, Bionorica SE and Canopy Growth have agreed to collaborate in long-term research.
The product portfolio comprises API & compounding kits for Dronabinol (THC), Cannabidiol (CBD) as well as other cannabinoid synthesis products for mainly pharmaceutical or analytical applications. Key therapeutic areas are pain and palliative treatment, oncology and neurology addressing a broad spectrum of chronic and severe illnesses.
C³ was founded in 2014 by Bionorica SE, one of the world’s leading producers of herbal medicines, as a holding company for the companies Bionorica ethics and THC Pharm. Both Bionorica ethics and THC Pharm have for almost two decades been researching and developing the key therapeutic ingredients of the cannabis flower: tetrahydrocannabinol and cannabidiol. Under the umbrella of C³, research, production and marketing have been pooled and optimized.
Canopy Growth Corporation is a world-leading diversified cannabis and hemp company, offering distinct brands and curated cannabis varieties in dried, oil and softgel capsule forms. Canopy Growth offers medically approved vaporizers through the Company’s subsidiary, Storz & Bickel GmbH & Co. KG. From product and process innovation to market execution, Canopy Growth is driven by a passion for leadership and a commitment to building a world-class cannabis company one product, site and country at a time. The Company has operations in over a dozen countries across five continents.
Lincoln International acted as the exclusive financial advisor to the seller, managing a competitive M&A process with strong interest from various parties.
Meet our Senior Team
View More Transactions
Lincoln International is pleased to announce the sale of Parker Fitzgerald to Accenture.
Lincoln advises Bridges Fund Management on the financing of its acquisition of énergie Fitness
Lincoln International advises Nelipak Healthcare Packaging and Kohlberg & Company in the acquisition of Bemis Healthcare Packaging Europe
Lincoln International advises Jason Industries (NASDAQ: JASN) in the divestiture of Janesville to Motus Integrated Technologies, a portfolio company of Atlas Holdings